On Thursday, at the end of its November meeting, the Fed announced a reduction of 0.25 percentage points in the federal funds ...
OpenAI is currently working on post-training for Orion, a process that involves incorporating human feedback to improve responses and refine the model's interaction with users. However, the model is ...
When thinking about stocks with recession-resistant characteristics, a few key metrics come to mind. First are low-beta ...
About This EventThe Hackett Group (Nasdaq: HCKT), a global leader in Gen AI consulting and business transformation, visits the Nasdaq MarketSite in Times Square to ring the Opening Bell to celebrate ...
Chevron Corporation ( CVX ), headquartered in San Ramon, California, integrates energy and chemicals operations. With a ...
About This EventSafe Horizon, the nation’s largest victim services organization, visits the Nasdaq MarketSite in Times Square in honor of National Homeless Youth Awareness Month and the 40th ...
At the end of October, Boeing announced the pricing of a public offering of 112.5 million shares at $143 and $5 billion in depositary shares, helping to shore up its balance sheet by almost $21.1 ...
Semiconductor company Nvidia (NASDAQ: NVDA) has seen its share price increase nearly 1,000% since the launch of ChatGPT in late 2022. That event was the big-bang moment for the artificial ...
Although Bezos passed the baton as Amazon's CEO to Andy Jassy, he remains the executive chair of the company's board of directors and one of its largest shareholders. Amazon inked deals earlier this ...
Freshpet, Inc. (NASDAQ: FRPT), the leading fresh food company for dogs and cats, visits the Nasdaq MarketSite in Times Square to celebrate the 10th anniversary of their IPO. Sign up for our newsletter ...
Shares of Adobe have significantly underperformed the broader market over the past 52 weeks. ADBE has dipped 15.5% over this time frame, while the broader S&P 500 Index ( $SPX) has gained 36.8%. In ...
MANNHEIM, Germany, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed” or the “Company”), a clinical-stage immuno-oncology company ...